Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough

Clinical trial NCT04562155 · COMPLETED

Trial details

NCT number
NCT04562155
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory and/or Unexplained Chronic Cough
Start date
2020-10-02
Primary completion
2021-06-22
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.